APO Research
Talk to an analyst

APO RESEARCH · REPORT

Canagliflozin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Canagliflozin Market Analysis and Forecast 2026-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchCanagliflozin Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Canagliflozin Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Canagliflozin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Canagliflozin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Canagliflozin Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Canagliflozin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Canagliflozin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Canagliflozin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Canagliflozin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Canagliflozin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Canagliflozin include Hansoh Pharma, Mitsubishi Tanabe Pharma, Hinye and Janssen Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Canagliflozin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Canagliflozin, also provides the sales of main regions and countries. Of the upcoming market potential for Canagliflozin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Canagliflozin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Canagliflozin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Canagliflozin sales, projected growth trends, production technology, application and end-user industry.

Canagliflozin Segment by Company

Hansoh Pharma

Mitsubishi Tanabe Pharma

Hinye

Janssen Pharmaceuticals

Canagliflozin Segment by Type

100mg

300mg

Canagliflozin Segment by Application

Diabetes

Heart Disease

Others

Canagliflozin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canagliflozin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Canagliflozin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canagliflozin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Canagliflozin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Canagliflozin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Canagliflozin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Canagliflozin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 100mg Major Manufacturers Table 3. 300mg Major Manufacturers Table 4. Global Canagliflozin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Diabetes Major Manufacturers Table 6. Heart Disease Major Manufacturers Table 7. Others Major Manufacturers Table 8. Canagliflozin Industry Trends Table 9. Canagliflozin Industry Drivers Table 10. Canagliflozin Industry Opportunities and Challenges Table 11. Canagliflozin Industry Restraints Table 12. Global Canagliflozin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Canagliflozin Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Canagliflozin Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Canagliflozin Revenue Market Share by Region (2021-2026) Table 16. Global Canagliflozin Revenue Market Share by Region (2027-2032) Table 17. Global Canagliflozin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Canagliflozin Sales by Region (2021-2026) & (K Units) Table 19. Global Canagliflozin Sales by Region (2027-2032) & (K Units) Table 20. Global Canagliflozin Sales Market Share by Region (2021-2026) Table 21. Global Canagliflozin Sales Market Share by Region (2027-2032) Table 22. Global Canagliflozin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Canagliflozin Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Canagliflozin Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Canagliflozin Sales Market Share by Manufacturers (2021-2026) Table 26. Global Canagliflozin Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Canagliflozin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Canagliflozin Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Canagliflozin Manufacturers, Product Type & Application Table 30. Global Canagliflozin Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Canagliflozin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Canagliflozin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Canagliflozin Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Canagliflozin Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Canagliflozin Revenue Market Share by Type (2021-2026) Table 37. Global Canagliflozin Revenue Market Share by Type (2027-2032) Table 38. Global Canagliflozin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Canagliflozin Sales by Type (2021-2026) & (K Units) Table 40. Global Canagliflozin Sales by Type (2027-2032) & (K Units) Table 41. Global Canagliflozin Sales Market Share by Type (2021-2026) Table 42. Global Canagliflozin Sales Market Share by Type (2027-2032) Table 43. Global Canagliflozin Price by Type (2021-2026) & (US$/Unit) Table 44. Global Canagliflozin Price by Type (2027-2032) & (US$/Unit) Table 45. Global Canagliflozin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Canagliflozin Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Canagliflozin Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Canagliflozin Revenue Market Share by Application (2021-2026) Table 49. Global Canagliflozin Revenue Market Share by Application (2027-2032) Table 50. Global Canagliflozin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Canagliflozin Sales by Application (2021-2026) & (K Units) Table 52. Global Canagliflozin Sales by Application (2027-2032) & (K Units) Table 53. Global Canagliflozin Sales Market Share by Application (2021-2026) Table 54. Global Canagliflozin Sales Market Share by Application (2027-2032) Table 55. Global Canagliflozin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Canagliflozin Price by Application (2027-2032) & (US$/Unit) Table 57. Hansoh Pharma Company Information Table 58. Hansoh Pharma Business Overview Table 59. Hansoh Pharma Canagliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Hansoh Pharma Canagliflozin Product Portfolio Table 61. Hansoh Pharma Recent Development Table 62. Mitsubishi Tanabe Pharma Company Information Table 63. Mitsubishi Tanabe Pharma Business Overview Table 64. Mitsubishi Tanabe Pharma Canagliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Mitsubishi Tanabe Pharma Canagliflozin Product Portfolio Table 66. Mitsubishi Tanabe Pharma Recent Development Table 67. Hinye Company Information Table 68. Hinye Business Overview Table 69. Hinye Canagliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Hinye Canagliflozin Product Portfolio Table 71. Hinye Recent Development Table 72. Janssen Pharmaceuticals Company Information Table 73. Janssen Pharmaceuticals Business Overview Table 74. Janssen Pharmaceuticals Canagliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Janssen Pharmaceuticals Canagliflozin Product Portfolio Table 76. Janssen Pharmaceuticals Recent Development Table 77. North America Canagliflozin Revenue by Type (2021-2026) & (US$ Million) Table 78. North America Canagliflozin Revenue by Type (2027-2032) & (US$ Million) Table 79. North America Canagliflozin Sales by Type (2021-2026) & (K Units) Table 80. North America Canagliflozin Sales by Type (2027-2032) & (K Units) Table 81. North America Canagliflozin Sales Price by Type (2021-2026) & (US$/Unit) Table 82. North America Canagliflozin Sales Price by Type (2027-2032) & (US$/Unit) Table 83. North America Canagliflozin Revenue by Application (2021-2026) & (US$ Million) Table 84. North America Canagliflozin Revenue by Application (2027-2032) & (US$ Million) Table 85. North America Canagliflozin Sales by Application (2021-2026) & (K Units) Table 86. North America Canagliflozin Sales by Application (2027-2032) & (K Units) Table 87. North America Canagliflozin Sales Price by Application (2021-2026) & (US$/Unit) Table 88. North America Canagliflozin Sales Price by Application (2027-2032) & (US$/Unit) Table 89. North America Canagliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Canagliflozin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 91. North America Canagliflozin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 92. North America Canagliflozin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 93. North America Canagliflozin Sales by Country (2021-2026) & (K Units) Table 94. North America Canagliflozin Sales by Country (2027-2032) & (K Units) Table 95. North America Canagliflozin Sales Price by Country (2021-2026) & (US$/Unit) Table 96. North America Canagliflozin Sales Price by Country (2027-2032) & (US$/Unit) Table 97. United States Canagliflozin Revenue (2021-2032) & (US$ Million) Table 98. Canada Canagliflozin Revenue (2021-2032) & (US$ Million) Table 99. Europe Canagliflozin Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe Canagliflozin Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe Canagliflozin Sales by Type (2021-2026) & (K Units) Table 102. Europe Canagliflozin Sales by Type (2027-2032) & (K Units) Table 103. Europe Canagliflozin Sales Price by Type (2021-2026) & (US$/Unit) Table 104. Europe Canagliflozin Sales Price by Type (2027-2032) & (US$/Unit) Table 105. Europe Canagliflozin Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Canagliflozin Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Canagliflozin Sales by Application (2021-2026) & (K Units) Table 108. Europe Canagliflozin Sales by Application (2027-2032) & (K Units) Table 109. Europe Canagliflozin Sales Price by Application (2021-2026) & (US$/Unit) Table 110. Europe Canagliflozin Sales Price by Application (2027-2032) & (US$/Unit) Table 111. Europe Canagliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Canagliflozin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. Europe Canagliflozin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. Europe Canagliflozin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 115. Europe Canagliflozin Sales by Country (2021-2026) & (K Units) Table 116. Europe Canagliflozin Sales by Country (2027-2032) & (K Units) Table 117. Europe Canagliflozin Sales Price by Country (2021-2026) & (US$/Unit) Table 118. Europe Canagliflozin Sales Price by Country (2027-2032) & (US$/Unit) Table 119. Germany Canagliflozin Revenue (2021-2032) & (US$ Million) Table 120. France Canagliflozin Revenue (2021-2032) & (US$ Million) Table 121. U.K. Canagliflozin Revenue (2021-2032) & (US$ Million) Table 122. Italy Canagliflozin Revenue (2021-2032) & (US$ Million) Table 123. Netherlands Canagliflozin Revenue (2021-2032) & (US$ Million) Table 124. China Canagliflozin Revenue by Type (2021-2026) & (US$ Million) Table 125. China Canagliflozin Revenue by Type (2027-2032) & (US$ Million) Table 126. China Canagliflozin Sales by Type (2021-2026) & (K Units) Table 127. China Canagliflozin Sales by Type (2027-2032) & (K Units) Table 128. China Canagliflozin Sales Price by Type (2021-2026) & (US$/Unit) Table 129. China Canagliflozin Sales Price by Type (2027-2032) & (US$/Unit) Table 130. China Canagliflozin Revenue by Application (2021-2026) & (US$ Million) Table 131. China Canagliflozin Revenue by Application (2027-2032) & (US$ Million) Table 132. China Canagliflozin Sales by Application (2021-2026) & (K Units) Table 133. China Canagliflozin Sales by Application (2027-2032) & (K Units) Table 134. China Canagliflozin Sales Price by Application (2021-2026) & (US$/Unit) Table 135. China Canagliflozin Sales Price by Application (2027-2032) & (US$/Unit) Table 136. Asia Canagliflozin Revenue by Type (2021-2026) & (US$ Million) Table 137. Asia Canagliflozin Revenue by Type (2027-2032) & (US$ Million) Table 138. Asia Canagliflozin Sales by Type (2021-2026) & (K Units) Table 139. Asia Canagliflozin Sales by Type (2027-2032) & (K Units) Table 140. Asia Canagliflozin Sales Price by Type (2021-2026) & (US$/Unit) Table 141. Asia Canagliflozin Sales Price by Type (2027-2032) & (US$/Unit) Table 142. Asia Canagliflozin Revenue by Application (2021-2026) & (US$ Million) Table 143. Asia Canagliflozin Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Canagliflozin Sales by Application (2021-2026) & (K Units) Table 145. Asia Canagliflozin Sales by Application (2027-2032) & (K Units) Table 146. Asia Canagliflozin Sales Price by Application (2021-2026) & (US$/Unit) Table 147. Asia Canagliflozin Sales Price by Application (2027-2032) & (US$/Unit) Table 148. Asia Canagliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia Canagliflozin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Asia Canagliflozin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Asia Canagliflozin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 152. Asia Canagliflozin Sales by Country (2021-2026) & (K Units) Table 153. Asia Canagliflozin Sales by Country (2027-2032) & (K Units) Table 154. Asia Canagliflozin Sales Price by Country (2021-2026) & (US$/Unit) Table 155. Asia Canagliflozin Sales Price by Country (2027-2032) & (US$/Unit) Table 156. Japan Canagliflozin Revenue (2021-2032) & (US$ Million) Table 157. South Korea Canagliflozin Revenue (2021-2032) & (US$ Million) Table 158. India Canagliflozin Revenue (2021-2032) & (US$ Million) Table 159. Australia Canagliflozin Revenue (2021-2032) & (US$ Million) Table 160. China Taiwan Canagliflozin Revenue (2021-2032) & (US$ Million) Table 161. Southeast Asia Canagliflozin Revenue (2021-2032) & (US$ Million) Table 162. SAMEA Canagliflozin Revenue by Type (2021-2026) & (US$ Million) Table 163. SAMEA Canagliflozin Revenue by Type (2027-2032) & (US$ Million) Table 164. SAMEA Canagliflozin Sales by Type (2021-2026) & (K Units) Table 165. SAMEA Canagliflozin Sales by Type (2027-2032) & (K Units) Table 166. SAMEA Canagliflozin Sales Price by Type (2021-2026) & (US$/Unit) Table 167. SAMEA Canagliflozin Sales Price by Type (2027-2032) & (US$/Unit) Table 168. SAMEA Canagliflozin Revenue by Application (2021-2026) & (US$ Million) Table 169. SAMEA Canagliflozin Revenue by Application (2027-2032) & (US$ Million) Table 170. SAMEA Canagliflozin Sales by Application (2021-2026) & (K Units) Table 171. SAMEA Canagliflozin Sales by Application (2027-2032) & (K Units) Table 172. SAMEA Canagliflozin Sales Price by Application (2021-2026) & (US$/Unit) Table 173. SAMEA Canagliflozin Sales Price by Application (2027-2032) & (US$/Unit) Table 174. SAMEA Canagliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. SAMEA Canagliflozin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. SAMEA Canagliflozin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. SAMEA Canagliflozin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 178. SAMEA Canagliflozin Sales by Country (2021-2026) & (K Units) Table 179. SAMEA Canagliflozin Sales by Country (2027-2032) & (K Units) Table 180. SAMEA Canagliflozin Sales Price by Country (2021-2026) & (US$/Unit) Table 181. SAMEA Canagliflozin Sales Price by Country (2027-2032) & (US$/Unit) Table 182. Brazil Canagliflozin Revenue (2021-2032) & (US$ Million) Table 183. Argentina Canagliflozin Revenue (2021-2032) & (US$ Million) Table 184. Chile Canagliflozin Revenue (2021-2032) & (US$ Million) Table 185. Colombia Canagliflozin Revenue (2021-2032) & (US$ Million) Table 186. Peru Canagliflozin Revenue (2021-2032) & (US$ Million) Table 187. Saudi Arabia Canagliflozin Revenue (2021-2032) & (US$ Million) Table 188. Israel Canagliflozin Revenue (2021-2032) & (US$ Million) Table 189. UAE Canagliflozin Revenue (2021-2032) & (US$ Million) Table 190. Turkey Canagliflozin Revenue (2021-2032) & (US$ Million) Table 191. Iran Canagliflozin Revenue (2021-2032) & (US$ Million) Table 192. Egypt Canagliflozin Revenue (2021-2032) & (US$ Million) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Canagliflozin Distributors List Table 196. Canagliflozin Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Canagliflozin Image Figure 2. Global Canagliflozin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Canagliflozin Market Size Share 2021 VS 2025 VS 2032 Figure 4. 100mg Image Figure 5. 300mg Image Figure 6. Global Canagliflozin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Canagliflozin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Diabetes Image Figure 9. Heart Disease Image Figure 10. Others Image Figure 11. Global Canagliflozin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Canagliflozin Revenue (2021-2032) & (US$ Million) Figure 13. Global Canagliflozin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Canagliflozin Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Canagliflozin Revenue Market Share by Region (2021-2032) Figure 16. Global Canagliflozin Sales (2021-2032) & (K Units) Figure 17. Global Canagliflozin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Canagliflozin Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Canagliflozin Sales YoY (2021-2032) & (K Units) Figure 20. Europe Canagliflozin Sales YoY (2021-2032) & (K Units) Figure 21. China Canagliflozin Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Canagliflozin Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Canagliflozin Sales YoY (2021-2032) & (K Units) Figure 24. Global Canagliflozin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Canagliflozin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Canagliflozin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Canagliflozin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Canagliflozin Revenue Market Share by Type (2021-2032) Figure 30. Global Canagliflozin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Canagliflozin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Canagliflozin Sales Market Share by Type (2021-2032) Figure 33. Global Canagliflozin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Canagliflozin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Canagliflozin Revenue Market Share by Application (2021-2032) Figure 36. Global Canagliflozin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Canagliflozin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Canagliflozin Sales Market Share by Application (2021-2032) Figure 39. North America Canagliflozin Revenue Share by Type (2021-2032) Figure 40. North America Canagliflozin Sales Share by Type (2021-2032) Figure 41. North America Canagliflozin Revenue Share by Application (2021-2032) Figure 42. North America Canagliflozin Sales Share by Application (2021-2032) Figure 43. North America Canagliflozin Revenue Share by Country (2021-2032) Figure 44. North America Canagliflozin Sales Share by Country (2021-2032) Figure 45. Europe Canagliflozin Revenue Share by Type (2021-2032) Figure 46. Europe Canagliflozin Sales Share by Type (2021-2032) Figure 47. Europe Canagliflozin Revenue Share by Application (2021-2032) Figure 48. Europe Canagliflozin Sales Share by Application (2021-2032) Figure 49. Europe Canagliflozin Revenue Share by Country (2021-2032) Figure 50. Europe Canagliflozin Sales Share by Country (2021-2032) Figure 51. China Canagliflozin Revenue Share by Type (2021-2032) Figure 52. China Canagliflozin Sales Share by Type (2021-2032) Figure 53. China Canagliflozin Revenue Share by Application (2021-2032) Figure 54. China Canagliflozin Sales Share by Application (2021-2032) Figure 55. Asia Canagliflozin Revenue Share by Type (2021-2032) Figure 56. Asia Canagliflozin Sales Share by Type (2021-2032) Figure 57. Asia Canagliflozin Revenue Share by Application (2021-2032) Figure 58. Asia Canagliflozin Sales Share by Application (2021-2032) Figure 59. Asia Canagliflozin Revenue Share by Country (2021-2032) Figure 60. Asia Canagliflozin Sales Share by Country (2021-2032) Figure 61. SAMEA Canagliflozin Revenue Share by Type (2021-2032) Figure 62. SAMEA Canagliflozin Sales Share by Type (2021-2032) Figure 63. SAMEA Canagliflozin Revenue Share by Application (2021-2032) Figure 64. SAMEA Canagliflozin Sales Share by Application (2021-2032) Figure 65. SAMEA Canagliflozin Revenue Share by Country (2021-2032) Figure 66. SAMEA Canagliflozin Sales Share by Country (2021-2032) Figure 67. Canagliflozin Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Canagliflozin Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 300mg
Applications
  • Diabetes
  • Heart Disease
  • Others
Companies covered
  • Hansoh Pharma
  • Mitsubishi Tanabe Pharma
  • Hinye
  • Janssen Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Canagliflozin Market by Type
  3. 1.2.1 Global Canagliflozin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 100mg
  5. 1.2.3 300mg
  6. 1.3 Canagliflozin Market by Application
  7. 1.3.1 Global Canagliflozin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Diabetes
  9. 1.3.3 Heart Disease
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Canagliflozin Market Dynamics
  1. 2.1 Canagliflozin Industry Trends
  2. 2.2 Canagliflozin Industry Drivers
  3. 2.3 Canagliflozin Industry Opportunities and Challenges
  4. 2.4 Canagliflozin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Canagliflozin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Canagliflozin Revenue by Region
  3. 3.2.1 Global Canagliflozin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Canagliflozin Revenue by Region (2021-2026)
  5. 3.2.3 Global Canagliflozin Revenue by Region (2027-2032)
  6. 3.2.4 Global Canagliflozin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Canagliflozin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Canagliflozin Sales by Region
  9. 3.4.1 Global Canagliflozin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Canagliflozin Sales by Region (2021-2026)
  11. 3.4.3 Global Canagliflozin Sales by Region (2027-2032)
  12. 3.4.4 Global Canagliflozin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Canagliflozin Revenue by Manufacturers
  2. 4.1.1 Global Canagliflozin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Canagliflozin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Canagliflozin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Canagliflozin Sales by Manufacturers
  6. 4.2.1 Global Canagliflozin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Canagliflozin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Canagliflozin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Canagliflozin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Canagliflozin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Canagliflozin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Canagliflozin Manufacturers, Product Type & Application
  13. 4.7 Global Canagliflozin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Canagliflozin Market CR5 and HHI
  16. 4.8.2 2025 Canagliflozin Tier 1, Tier 2, and Tier 3
5 Canagliflozin Market by Type
  1. 5.1 Global Canagliflozin Revenue by Type
  2. 5.1.1 Global Canagliflozin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Canagliflozin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Canagliflozin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Canagliflozin Sales by Type
  6. 5.2.1 Global Canagliflozin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Canagliflozin Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Canagliflozin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Canagliflozin Price by Type
6 Canagliflozin Market by Application
  1. 6.1 Global Canagliflozin Revenue by Application
  2. 6.1.1 Global Canagliflozin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Canagliflozin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Canagliflozin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Canagliflozin Sales by Application
  6. 6.2.1 Global Canagliflozin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Canagliflozin Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Canagliflozin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Canagliflozin Price by Application
7 Company Profiles
  1. 7.1 Hansoh Pharma
  2. 7.1.1 Hansoh Pharma Company Information
  3. 7.1.2 Hansoh Pharma Business Overview
  4. 7.1.3 Hansoh Pharma Canagliflozin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Hansoh Pharma Canagliflozin Product Portfolio
  6. 7.1.5 Hansoh Pharma Recent Developments
  7. 7.2 Mitsubishi Tanabe Pharma
  8. 7.2.1 Mitsubishi Tanabe Pharma Company Information
  9. 7.2.2 Mitsubishi Tanabe Pharma Business Overview
  10. 7.2.3 Mitsubishi Tanabe Pharma Canagliflozin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mitsubishi Tanabe Pharma Canagliflozin Product Portfolio
  12. 7.2.5 Mitsubishi Tanabe Pharma Recent Developments
  13. 7.3 Hinye
  14. 7.3.1 Hinye Company Information
  15. 7.3.2 Hinye Business Overview
  16. 7.3.3 Hinye Canagliflozin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hinye Canagliflozin Product Portfolio
  18. 7.3.5 Hinye Recent Developments
  19. 7.4 Janssen Pharmaceuticals
  20. 7.4.1 Janssen Pharmaceuticals Company Information
  21. 7.4.2 Janssen Pharmaceuticals Business Overview
  22. 7.4.3 Janssen Pharmaceuticals Canagliflozin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Janssen Pharmaceuticals Canagliflozin Product Portfolio
  24. 7.4.5 Janssen Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Canagliflozin Market Size by Type
  2. 8.1.1 North America Canagliflozin Revenue by Type (2021-2032)
  3. 8.1.2 North America Canagliflozin Sales by Type (2021-2032)
  4. 8.1.3 North America Canagliflozin Price by Type (2021-2032)
  5. 8.2 North America Canagliflozin Market Size by Application
  6. 8.2.1 North America Canagliflozin Revenue by Application (2021-2032)
  7. 8.2.2 North America Canagliflozin Sales by Application (2021-2032)
  8. 8.2.3 North America Canagliflozin Price by Application (2021-2032)
  9. 8.3 North America Canagliflozin Market Size by Country
  10. 8.3.1 North America Canagliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Canagliflozin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Canagliflozin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Canagliflozin Market Size by Type
  2. 9.1.1 Europe Canagliflozin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Canagliflozin Sales by Type (2021-2032)
  4. 9.1.3 Europe Canagliflozin Price by Type (2021-2032)
  5. 9.2 Europe Canagliflozin Market Size by Application
  6. 9.2.1 Europe Canagliflozin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Canagliflozin Sales by Application (2021-2032)
  8. 9.2.3 Europe Canagliflozin Price by Application (2021-2032)
  9. 9.3 Europe Canagliflozin Market Size by Country
  10. 9.3.1 Europe Canagliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Canagliflozin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Canagliflozin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Canagliflozin Market Size by Type
  2. 10.1.1 China Canagliflozin Revenue by Type (2021-2032)
  3. 10.1.2 China Canagliflozin Sales by Type (2021-2032)
  4. 10.1.3 China Canagliflozin Price by Type (2021-2032)
  5. 10.2 China Canagliflozin Market Size by Application
  6. 10.2.1 China Canagliflozin Revenue by Application (2021-2032)
  7. 10.2.2 China Canagliflozin Sales by Application (2021-2032)
  8. 10.2.3 China Canagliflozin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Canagliflozin Market Size by Type
  2. 11.1.1 Asia Canagliflozin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Canagliflozin Sales by Type (2021-2032)
  4. 11.1.3 Asia Canagliflozin Price by Type (2021-2032)
  5. 11.2 Asia Canagliflozin Market Size by Application
  6. 11.2.1 Asia Canagliflozin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Canagliflozin Sales by Application (2021-2032)
  8. 11.2.3 Asia Canagliflozin Price by Application (2021-2032)
  9. 11.3 Asia Canagliflozin Market Size by Country
  10. 11.3.1 Asia Canagliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Canagliflozin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Canagliflozin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Canagliflozin Market Size by Type
  2. 12.1.1 SAMEA Canagliflozin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Canagliflozin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Canagliflozin Price by Type (2021-2032)
  5. 12.2 SAMEA Canagliflozin Market Size by Application
  6. 12.2.1 SAMEA Canagliflozin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Canagliflozin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Canagliflozin Price by Application (2021-2032)
  9. 12.3 SAMEA Canagliflozin Market Size by Country
  10. 12.3.1 SAMEA Canagliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Canagliflozin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Canagliflozin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Canagliflozin Value Chain Analysis
  2. 13.1.1 Canagliflozin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Canagliflozin Production Mode & Process
  6. 13.2 Canagliflozin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Canagliflozin Distributors
  9. 13.2.3 Canagliflozin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst